The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a funding opportunity titled "Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK." This initiative encourages pilot and feasibility clinical trials aiming to advance larger clinical studies related to diabetes, kidney diseases, and digestive disorders. The funding aims to support short-term proof-of-concept trials that gather preliminary data on interventions without requiring extensive prior data. Key details include a funding commitment of $1 million for fiscal year 2024, limited budget allocations of $200,000 per year for a maximum project period of three years, and eligibility extending to various institutions and organizations. Applicants are encouraged to involve diverse populations to address health disparities. Strict guidelines are set regarding submission, including the utilization of new NIH application forms and adherence to data management mandates. The program's goal is to foster innovation in clinical research by enabling smaller studies to overcome regulatory and financial barriers while contributing to improved health outcomes in targeted diseases. Overall, this funding opportunity aims to strengthen the clinical trial pipeline with a focus on intervention impact and public health implications.